Do all intravenous iron infusions cause hypophosphatemia?

Not all intravenous iron infusions uniformly cause hypophosphatemia; ferric carboxymaltose carries a notably higher risk compared to formulations like ferric derisomaltose, necessitating monitoring of phosphate levels.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-10
DOI
https://doi.org/10.5281/zenodo.24105474
Primary Topic
Iron Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Do all intravenous iron infusions cause hypophosphatemia?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Iron Metabolism and Disorders
article

Do all intravenous iron infusions cause hypophosphatemia?

Tripdatabase
article en

Abstract

Not all intravenous iron infusions uniformly cause hypophosphatemia; ferric carboxymaltose carries a notably higher risk compared to formulations like ferric derisomaltose, necessitating monitoring of phosphate levels.

Zenodo (CERN European Organization for Nuclear Research)
Iron Metabolism and Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Do all intravenous iron infusions cause hypophosphatemia? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS